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Alzheimer’s disease (AD) is the most common cause of dementia. Amyloid β (Abeta,
Aβ) deposition and intracellular tangles are the pathological hallmarks of AD. MicroRNAs
(miRNAs) are small non-coding RNAs, which have been found to play very important roles,
and have the potential to serve as diagnostic markers during neuronal pathogenesis.
In this study, we aimed to determine the roles of miR-99b-5p and miR-100-5p in Aβ-
induced neuronal pathologies. We detected the expression levels of miR-99b-5p and
miR-100-5p in the brains of APPswe/PS1ΔE9 double-transgenic mice (APP/PS1 mice)
at different age stages and found that both miRNAs were decreased at early stages while
increased at late stages of APP/PS1 mice when compared with the age-matched wild
type (WT) mice. Similar phenomenon was also observed in Aβ-treated cultured cells. We
also confirmed that mammalian target of rapamycin (mTOR) is one of the targets of miR-
99b-5p/100-5p, which is consistent with previous studies in cancer. MiR-99b-5p/100-5p
has been found to promote cell apoptosis with the Aβ treatment. This effect may be
induced via the mTOR pathway. In our study, we find both miR-99b-5p and miR-100-
5p affect neuron survival by targeting mTOR. We also speculate that dynamic change
of miR-99b-5p/100-5p levels during Aβ-associated pathologies might be attributed to
Aβ-induced endoplasmic reticulum stress (ER stress), suggesting the potential role of the
“ER stress–miRNAs–mTOR” axis in Aβ-related AD pathogenesis.
Keywords: microRNA-99b-5p, microRNA-100-5p, amyloid β, Alzheimer’s disease, endoplasmic reticulum stress
INTRODUCTION
Alzheimer’s disease (AD) is themost commonhumanneurodegenerative disease in the elderly;more
than 30 million people suffer from AD worldwide (Schonrock et al., 2012). The nosogenesis of AD
is widely accepted as amyloid-β peptide (Aβ) deposition caused by abnormal protein metabolism
Abbreviations: Aβ, amyloid β; AD, Alzheimer’s disease; APP, amyloid precursor protein; ER stress, endoplasmic reticulum
stress; MiRNA, microRNA; mTOR, mammalian target of rapamycin; PI3K, phosphatidylinositol 3-kinase; PS1, presenilin 1;
WT, wild type.
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and tau protein precipitation in AD brains. The AD progress
encompasses multiple alterations of gene expression and protein
reactions related to Aβ deposition, tau hyperphosphorylation,
inflammation, energy metabolism, cell cycle, and apoptosis (Bal-
lard et al., 2009; Schonrock et al., 2012). Aβ is themain component
of amyloid plaques, which trigger cascaded reaction, leading to
synaptic dysfunction, disrupting neural connectivity andneuronal
death (Murphy and LeVine, 2010). Recently, lots of studies have
demonstrated that aberrant levels of microRNAs (miRNAs) are
widely involved in AD brains, indicating a complicated regulatory
network of miRNAs in the etiopathology of AD (Schratt et al.,
2006; Cheng et al., 2009; Magill et al., 2010; Zhao et al., 2010).
MicroRNAs are non-coding RNAs with 21–25 nt, which origi-
nate from both intergenic and intronic regions, inhibiting protein
expression in a post-transcriptional manner by interacting with
the 30-UTR of target mRNAs (Ambros, 2004). A single miRNA
has the ability to target thousands of mRNAmolecules. Moreover,
there are hundreds of potential miRNA-binding sites in just one
mRNAmolecule. MiRNAs have been reported to be involved in a
wide spectrum of human diseases, especially in cancer, infectious
diseases, cardiac diseases, andmany others (Ardekani and Naeini,
2010; Tufekci et al., 2014). Accumulating evidences show that
miRNAs also participate in numerous neurodegenerative disor-
ders, including AD, Amyotrophic lateral sclerosis, Parkinson’s dis-
ease, andHuntington’s disease (Kim et al., 2007). Recent studies of
AD have demonstrated aberrant miRNA expression profile in AD
via developed sequencing approach (Nunez-Iglesias et al., 2010;
Shioya et al., 2010). The roles of miRNAs in APP and Aβ produc-
tion, synaptic remodeling, neuron survival, and glia cell activation
have also been identified (Kurosinski and Gotz, 2002; Kocerha
et al., 2009; Schratt, 2009). Nevertheless, there are far more miR-
NAs remaining enigmatic as to their roles in AD etiology.
Our previous study found that miR-99b-5p and miR-100-5p
were abnormally expressed in the brains of APPswe/PS1ΔE9
double-transgenic mice [APP/PS1 mice (Luo et al., 2014)], which
have AD symptoms after 6months of age, suggesting their pivotal
roles in Aβ deposition-associated AD pathology. MiR-99b-5p
and miR-100-5p belong to the same miR-99 family, which con-
sists of three members, miR-99a, miR-99b, and miR-100. Studies
have shown that miR-99 family regulates cell survival, cell stress
response, proliferation, angiogenesis, DNA damage, and wound
healing process (Zhang et al., 2009; Doghman et al., 2010; Sun
et al., 2011; Chen et al., 2012; Zheng et al., 2012; Jin et al., 2013;
Mueller et al., 2013). It has been reported that mammalian target
of rapamycin (mTOR) is one of the targets of both miR-99 and
miR-100 (Sun et al., 2011; Li et al., 2013; Xu et al., 2013).
Mammalian target of rapamycin is a conserved serine–
threonine kinase, belonging to the phosphatidylinositol 3-kinase
(PI3K)-related kinase protein family. This kinase family plays
essential roles in cell apoptosis, proliferation and differentiation,
cell senescence, cytoskeleton composition, angiogenesis, gene
transcription, tumor formation, and development, mainly via
PI3K/Akt/mTOR signaling pathway (Hassan et al., 2013; Maiese
et al., 2013; Trigka et al., 2013). Interestingly, emerging evidences
demonstrate that mTOR regulates neuron survival, neuronal pro-
tection, autophagy, synaptic development, and function in nerve
system (Chen et al., 2010; Heras-Sandoval et al., 2014). Previous
studies have illustrated that both in patient cases andmouse mod-
els of AD, Aβ can inhibit mTOR pathway, leading to dysregulation
of tau, phosphatase and tensin homolog (PTEN), and neuronal
survival as well as plasticity (Chen et al., 2010). In addition,mTOR
is associatedwith clearance ofAβ, synaptic remodeling, long-term
potentiation (LTP), and cognitive decline (Jaworski et al., 2005;
Paccalin et al., 2006; Hoeffer and Klann, 2010; Ma et al., 2010),
indicating its predominant roles in AD development. Therefore,
the role of mTOR under the regulation of miR-99b-5p and miR-
100-5p in Aβ-induced neuronal pathologies needs to be further
illuminated.
In this study, we used APP/PS1 mice to determine the role
of miR-99b-5p and miR-100-5p in Aβ-associated brain patholo-
gies. Our work first demonstrated that miR-99b-5p/100-5p levels
exhibited a dynamic change along the Aβ deposition, which could
also be recapitulated in Aβ-treated cells in vitro. We presumed
that this dynamic change of both miRNAs might be due to Aβ-
induced endoplasmic reticulum stress (ER stress). Moreover, we
found that miR-99b-5p/100-5p played a pivotal role via targeting
mTOR, indicating that the ER stress–miRNAs–mTOR axis might
give us a novel clue to understand Aβ-induced AD pathology.
MATERIALS AND METHODS
Animal Samples
The APP/PS1 mice [held by The Jackson Laboratory, stain
name: “B6.Cg-Tg(APPswe, PSEN1dE9)85Dbo/Mmjax” (Borchelt
et al., 1996)] were purchased from the Model Animal Research
Center of Nanjing University. The non-carrier C57BL/6J mice
were used as the wild type (WT) control. Six to eight pairs of
APP/PS1 and WT mice at different age stages were included in
this study. All the mice were anesthetized with pentobarbital
(50mg/kg). Then, 0.5ml of peripheral whole blood was kept in
anticoagulation tubes with EDTA. Cortexes of the brains were
dissected and lysed for either RNA or protein extraction. All
the animal experiments were performed in accordance with
animal use guidelines approved by the Committee for the Ethics
of Animal Experiment, Shenzhen-Peking University, The Hong
Kong University of Science and Technology Medical Center
(SPHMC). The protocol number is 2011-004.
Reagents and Antibodies
Amyloid-β peptide 1–42 (Aβ1–42) was from AnaSpec (AS-
20276). The ER stress inhibitor sodium phenylbutyrate (PBA) and
inducer thapsigargin (TG) were both from Sigma. PBA and TG
were dissolved in ethanol and used with the final concentration of
10mM and 500 nM, respectively. MiRNA mimics and inhibitors
were purchased from Invitrogen. Mouse monoclonal antibodies
of GAPDH and β-actin were from Sangon, and rabbit polyclonal
antibody of mTOR was from Cell Signaling Technology.
Cell Culture and Aβ Treatment
Rat pheochromocytoma cells – PC12 (ATCC) were routinely
cultured in DMEM (GIBCO) containing 6% fetal bovine serum
(Hyclone), 6% horse serum (GIBCO), 50U/ml penicillin, and
50μg/ml streptomycin (GIBCO) in a humidified incubator at
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37°C with 7.5% CO2. PC12 cell differentiation was induced by
NGF. Cells were plated 1 day before treatment with NGF. After
incubating for 1 day, culture medium was changed to differen-
tiation medium (DMEM with 50 ng/ml NGF, 0.5% fetal bovine
serum, 0.5% horse serum and penicillin/streptomycin). Primary
cortical neuron cultures were prepared from embryonic day 18
rat embryos (Wan et al., 2008). Cortical neurons were plated and
cultured on poly-L-lysine (PLL)-precoated culture plates in Neu-
robasal A medium containing B27 supplement, 0.05mM glucose,
and 0.5mM L-glutamine in a 37°C, 5% CO2 incubator. Culture
medium was half-changed every 2 days. Aβ1–42 oligomers were
prepared by dissolving Aβ1–42 powder in 1% NH4OH followed
by diluting to 0.2mM in PBS, and incubating in 37°C water
bath overnight. Aβ1–42 with different final concentrations was
treated with cortical neurons cultured at 7-day in vitro (DIV7) or
differentiated PC12 cells (NGF treatment for 48 h) for various time
intervals as indicated.
Plasma MicroRNAs Quantification Based
on Taqman Probe qPCR
Whole blood samples fromdifferent ages ofmice were centrifuged
at 2,000 rpm for 10min at room temperature. The separated
plasmawas stored at 80°C. RNAwas isolated from150μl plasma
by Trizol Reagent (Invitrogen) for Taqman probe-based (Invit-
rogen) qPCR analysis as described before (Wang et al., 2015).
Both miR-99b-5p and miR-100-5p mimics were used to establish
standard curves for the determination of the miRNAs copies in
plasma. All probe-based qPCR was done using Lightcycler 480
probe Master (Roche) according to the manufacturer’s instruc-
tions. For normalization of sample variation, 5 ng internal con-
trol Mmu-miR-486 and external miRNAs control Cel-miR-238
were added to each plasma sample for extraction and qRT-PCR.
The statistical analyses were performed using the methods as
described before (Wang et al., 2015). The probe sequences were
listed in Table 1.
RNA Extraction and Real-Time PCR
Total RNA was extracted by Trizol Reagent (Invitrogen) from
either mice brains or cultured cells, followed by reverse transcrip-
tion as described previously (Luo et al., 2014). CDNAs were then
used as the templates in Real-time PCR using iQ™ SYBR® Green
Supermix (BIO-RAD). ThemRNA level ofmTORwas normalized
by the average levels of GAPDH, while miRNA was by the levels
of snRNAU6. The delta–deltaCt method was used in this study to
quantify the fold change of both mRNA andmiRNAs. The primer
sequences were listed in Table 1.
Transient Transfection
PC12 cells were plated on PLL-coated culture plates in growth
medium at 16 h before the transfection. One hundred nanomole
miRNAs (Invitrogen) were transfected into PC12 cells using Lipo-
fectamine 2000 Reagent (Invitrogen) according to the manufac-
turer’s instruction. Immediately after isolated from the embryo
cortexes, primary cortical neurons were transfected with the miR-
NAs using Neon™ MPK 5000S Transfection system (Invitrogen)
according to themanufacturer’s protocol. The transfected neurons
TABLE 1 | Sequence of the primers used for real-time PCR.
Primer/probe Sequence
Has miR-R 50-GTGCGTGTCGTGGAGTC-30
snRNAU6-F 50-GCTTCGGCAGCACATATACTAAAAT-30
snRNAU6-R 50-CGCTTCACGAATTTGCGTGTCAT-30
miR-99b-5p-F 50-CACCCGTAGAACCGACCTT-30
miR-99b-5p-R 50-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGC
ACTGGATACGACCGCAAGG-30
miR-100-5p-F 50-AAGAGAACCCGTAGATCCG-30
miR-100-5p-R 50-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGC
ACTGGATACGACCACAAG-30
MsGAPDH-F 50-AACTTTGGCATTGTGGAAGG-30
MsGAPDH-R 50-AACTTTGGCATTGTGGAAGG-30
RatGAPDH-F 50-TGTGAACGGATTTGGCCGTA-30
RatGAPDH-R 50-TGTGAACGGATTTGGCCGTA-30
mTOR-F 50-CTTCTTCCGTTCTATCTCCTT-30
mTOR-R 50-CTTCTTCCGTTCTATCTCCTT-30
Mmu-miR-486-F 50-ACCGTCCTGTACTGAGCT-30
Mmu-miR-486-R 50-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGC
ACTGGATACGACCTCGGG-30
Cel-miR-238-F 50-AGCCTTTGTACTCCGATGC-30
Cel-miR-238-R 50-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGC
ACTGGATACGACTCTGAA-30
miR-99b-5p probe 50-CACTGGATACGACCGCAAGGTCG-30
miR-100-5p probe 50-CACTGGATACGACCACAAGTTCGGT-30
were plated on PLL-coated plates and cultured for 7 days before
different treatments.
Western Blot Assay
Brain tissues or cultured cells were lysed in RIPA buffer [150mM
NaCl, 1% (v/v) Nonidet P-40, 0.5% deoxycholic acid, 0.1% (w/v)
SDS] containing protease inhibitors (cocktail, Sangon) and 1mM
phenylmethanesulfonyl fluoride (Sigma). The lysate was cen-
trifuged at 4°C, 14,000 rpm for 15min to get the supernatants.
The proteins separated by SDS-PAGEwere transferred onto PVDF
membranes. GAPDH, β-actin, andmTORantibodieswere used in
this study.
Cell Viability Assays
To evaluated the cell viability, CellTiter 96 AQueous (Promega)
was added to PC12 cells or primary cortical neurons at 1/10
volume of the medium. Cells were incubated at 37°C for 4 h. Two
hundred microliters of mixed medium was transferred into 96-
well ELISA plate. The absorbance was measured at 490 nm using
a Microplate reader (BIO-RAD). Cell viability was presented as
the percentage of absorbance obtained in control cells.
Statistical Analysis
Data are represented as mean SD. Statistical analysis of the data
was performed with Student’s t test using SPSS 13.0 software. A
value of p< 0.05(*) was considered statistically significant.
RESULTS
miR-99b-5p and miR-100-5p Are Involved
in Aβ-Induced Alzheimer’s Disease
Our previous study demonstrated that miR-99b-5p/miR-100-
5p was upregulated in 9-month-old APP/PS1 mice cortexes
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via high-throughput sequencing (Luo et al., 2014). To fur-
ther explore the association of miR-99b-5p/miR-100 with Aβ-
associated pathologies, real-time PCR was performed to deter-
mine the expression pattern along the aging progress in six to
eight pairs of APP/PS1 and WT mice at each indicated age stage
(2-, 4-, 6-, 9-, 12-, and 15-month-old). The expression levels
of miR-99b-5p and miR-100-5p were significantly decreased at
early stages (6 and 9months) but increased at late stages (12 and
15months) of APP/PS1 mice when compared with age-matched
WT mice (Figure 1A), indicating that miR-99b-5p and miR-
100-5p are dynamically regulated and exert their functions in
accordance with different stages of brain pathologies induced by
Aβ deposition.
In order to verify whether miR-99b-5p and miR-100-5p were
detectable in mice plasma and thus could be used as biomark-
ers for diagnosis of AD, we detected the plasmatic copy num-
bers of two miRNAs via Taqman probe-based qPCR. After the
normalization and calculation by referring to standard curve,
we found that APP/PS1 mice showed higher expression levels
of miR-99b-5p and miR-100-5p at 2, 4, 6, and 9months in
plasma, but lower at 12months as well as 15months (Figure 1B).
This trend is opposite to the results in cortex tissues, indicat-
ing that the biogenesis, circulation, and distribution of miR-
99b-5p and miR-100-5p along the development of Aβ-induced
pathologies might be regulated by complicated yet sophisticated
machinery.
To further investigate the expression pattern of two miRNAs
after Aβ-treatment, we also used PC12 cell model. At the early
stage of Aβ-treatment (6 h), miR-99b-5p/miR-100-5p levels were
declined. Afterwards, the expression of both miRNAs was ele-
vated, especially in the high concentration groups (Figure 1C),
which is consistent with the data from mice tissues.
mTOR Is One of the Targets of miR-99b-5p
and miR-100-5p in PC12 Cells
In order to shed light on the functionality ofmiR-99b-5p andmiR-
100-5p in Aβ-induced pathologies, we predicted the potential
FIGURE 1 | The expression levels of miR-99b-5p and miR-100-5p in APP/PS1 mice and Aβ-treated PC12 cells. (A) Relative expression levels (presented as
fold change) of miR-99b-5p/miR-100-5p were quantified in six to eight pairs of APP/PS1 and WT mice cortexes by real-time PCR. The levels were normalized to the
expression of snRNAU6 using the delta–deltaCt methods. (B) The absolute copy number of plasma miRNAs were calculated by referring to the standard curve and
normalized with the Ct of mmu-miR-486 and cel-miR-238. Data are represented as meanSD, results were analyzed with Student’s t test (*p<0.05, n= 3).
(C) PC12 cells were differentiated for 48 h before the treatments with different concentrations of Aβ1–42 oligomers (0.05, 0.1, 0.5, and 4.0μM) for various time
intervals. Relative expression levels of miR-99b-5p and miR-100-5p are represented as fold change compared to vehicle controls. Data are expressed as meanSD
and results were analyzed with Student’s t test [*p<0.05, compared with control (n= 6)].
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targets of these two miRNAs using three online target predic-
tion databases (miRDB, miRanda, and TargetScan) (Luo et al.,
2014). Among the potential targets, mTOR was taken into con-
sideration, which had been proved as one of the major targets
of miR-99 family. Overexpression of miR-99b-5p and miR-100-
5p dramatically reduced the mRNA and protein levels of mTOR
in PC12 cells. In contrast, the miRNAs inhibitors only led to
the upregulation effect on mTOR protein level but not mRNA
level (Figures 2A,B). The expression level of mTOR protein in
mice cortexes was also investigated. In 9-month-old APP/PS1
cortexes, mTOR level was higher than that in the age-matched
WT mice cortex tissues, whereas it was lower in 12-month-old
APP/PS1 cortexes than in the age-matched WT mice cortexes
(Figures 2C,D). In Aβ-treated PC12 cells, the mTOR expres-
sion was also downregulated (Figure 2E). The inverse-correlated
expression profile of miR-99b-5p/miR-100-5p and mTOR also
indicates that miRNAs-regulated mTOR pathway may play dif-
ferent roles during the progression of brain injuries induced by
Aβ deposition.
miR-99b-5p and miR-100 Inhibit Cell
Viability of Primary Neurons and PC12 Cells
To determine the role of miR-99b-5p and miR-100-5p in cell
viability, we transfected the mimics or inhibitors of miR-99b-5p
and miR-100-5p to primary rat cortical neurons or PC12 cells,
respectively. Then the cells were treated with Aβ1–42 for 24 h.
The viability of primary rat neurons was dramatically decreased
whenmiR-99b-5p or miR-100-5p was overexpressed. On the con-
trary, cell viability was increased when miR-99b-5p or miR-100-
5p was inhibited (Figure 3A). In PC12 cells, we also observed the
similar results (Figure 3B), suggesting that either miR-99b-5p or
FIGURE 2 | Both miR-99b-5p and miR-100-5p negatively regulate mTOR expression in PC12 cells as well as in APP/PS1 mice. (A,B) MiR-99b-5p and
miR-100-5p mimics or inhibitors were transfected in PC12 cells. mTOR mRNA or protein levels were analyzed by real-time PCR or western blot, respectively. Data
are represented as meanSD and results were analyzed with Student’s t test (*p<0.05, n= 4). (C,D) Western blot analysis of mTOR protein level in cortex tissues
from 9 and 12months old APP/PS1 and WT mice. The housekeeping gene β-actin was taken as the internal reference. (E) Western blot of mTOR expression in
PC12 at 0, 12, 24, and 48 h after the treatment of Aβ1-42.
FIGURE 3 |MiR-99b-5p and miR-100-5p reduce cell viability. (A) Cell viability assay in primary neurons with the transfection of miR-99b-5p/miR-100-5p mimics
or inhibitors. (B) Co-transfection of miR-99b-5p and miR-100-5p mimics or inhibitors varied the cell viability in PC12 cells. Data are represented as meanSD;
n= 3. Results were analyzed with Student’s t test (*p<0.05).
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miR-100-5p can further promote the neuronal cell death induced
by Aβ1–42.
The Expression Change of miR-99b-5p and
miR-100-5p Induced by Aβ is Related to ER
Stress
To determine whether the dynamic change of miR-99b-5p and
miR-100-5p is related to Aβ-induced ER stress, we induced ER
stress by TG in differentiated PC12 cells. Similar to Aβ treatment,
TG also induced the decrease of two miRNAs at early stage
but increase at late stage (Figure 4A). When we used ER stress
inhibitor PBA to treat PC12 cells together with Aβ, the levels
of miR-99b-5p and miR-100-5p after Aβ treatment were further
upregulated (Figure 4B).
DISCUSSION
Many studies have showed the importance of mTOR signaling in
brain. Neurons utilize mTOR to modulate multiple brain func-
tions, including regulation of feeding, synaptic plasticity, and
memory formation (Garelick and Kennedy, 2011). The cross
talk of mTOR pathway with other signaling pathways has been
indicated in autophagy, Aβ clearance, and AD development
(Godoy et al., 2014). It has been demonstrated that the miR-99
can repress three targets: mTOR, SMARCA5 (SWI/SNF-related,
matrix-associated, actin-dependent regulator of chromatin, sub-
family a, member 5), and SMARCD1 (SWI/SNF-related, matrix-
associated, actin-dependent regulator of chromatin, subfamily d,
member 1) (Sun et al., 2011). mTOR, PLK1 (Polo-like kinase
1), FKBP51 (FK506 binding protein 51), IGF1R (insulin-like
growth factor 1 receptor), IGF2 (insulin-like growth factor 2), and
HOXA1 (homeobox A1) have been proved as the target genes of
miR-100 (Nagaraja et al., 2010; Li et al., 2011, 2013; Gebeshuber
and Martinez, 2013; Xu et al., 2013; Xiao et al., 2014). Here,
mTOR is a common target of miR-99 and miR-100, and it is
also a pivotal molecule involved in neurodegenerative diseases.
To date, the functional role of mTOR in AD development is still
enigmatic. However, several studies have suggested that inhibition
of mTOR by rapamycin improves cognitive deficits and rescues
Aβ pathology and NFTs through increased autophagy (Caccamo
et al., 2010; Santos et al., 2011; Cai et al., 2012). In our study,
we found that mTOR level was decreased at late stages of Aβ
deposition mouse model cortexes. It is worthwhile to scruti-
nize whether mTOR plays positive roles in preventing neuronal
death as early onset of Aβ deposition, and downregulation of
mTOR at late stage ultimately leads to apoptosis of neuronal
cells.
MicroRNA-99 family was found to be deregulated in different
cancer types (Zhang et al., 2009; Doghman et al., 2010; Sun
et al., 2011; Chen et al., 2012; Zheng et al., 2012; Jin et al., 2013;
Mueller et al., 2013), but the role of miR-99 family in neuronal
cell differentiation or cell death is not clear. Recently, Denk et al.
(2015) found that miR-100 in cerebrospinal fluid (CSF) from AD
patients could serve as one of the reliable biomarkers to detect AD.
In this study, we chose APP/PS1 mice to explore the link between
miR-99b-5p/miR-100-5p and Aβ-induced pathological develop-
ment. Interestingly, the expression levels of miR-99b-5p and
miR-100 in APP/PS1 mice brains were decreased at early stages
(6–9months old) and increased at late stages (12–15months
old) when compared with age-matched WT mice. This result
suggests that miR-99b-5p/miR-100-5p play distinct roles during
different stages of Aβ deposition-induced brain pathologies. To
explain the underlying mechanism that orchestrates dynamic
change of two miRNAs during the progression of Aβ-associated
pathologies, we speculated ER stress as the regulator of the two
miRNAs.
ER stress is triggered by the loss of homeostasis in the ER,
leading to the accumulation of misfolded proteins within the
ER lumen. Aβ was found to induce mild ER stress (Chafekar
et al., 2007).We hypothesized that the change ofmiR-99b-5p/100-
5p induced by Aβ was through ER stress induction, and we
confirmed it by both activator and inhibitor of ER stress. The
unfolded protein response (UPR) is a highly conserved stress
response, functioning as a short-term adaptive mechanism to
reduce unfolded protein levels and restore balance to the ER.
However, if the UPR is insufficient to clear the unfolded proteins,
another pathway, CHOP pathway, is activated, and ER stress-
induced cell death occurs (Logue et al., 2013). APP and its process-
ing products were found to have potential role inUPR (Endres and
Reinhardt, 2013). Aβ can induce ER stress in both cultured neu-
rons and animal models (Lee et al., 2010; Costa et al., 2013; Kondo
et al., 2013). In our APP/PS1 mice, we could detect ER stress
markers (PERK, eIF2α, and CHOP) at different stages, which
were correlated with the change of miRNAs (data not shown). At
UPR stages (6–9months), the levels of miR-99b-5p/miR-100-5p
FIGURE 4 | ER stress regulates miR-99b-5p and miR-100-5p. (A) NGF-differentiated PC12 cells were treated with TG (500 nM) for different time intervals as
indicated. Total RNA was extracted. MiR-99b-5p and miR-100-5p were half-quantified by real-time PCR. (B) Aβ was treated to differentiated PC12 cells with or
without PBA for 24 h, and the qRT-PCR was performed as (A). Data are expressed as meanSD and results were analyzed with Student’s t test (*p<0.05).
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were decreased, which were beneficial for neuron survival and
synaptic plasticity. However, at late stages, due to long exposure
to Aβ, the ER stress-induced death signaling was activated, and
two miRNAs were increased to induce neuronal apoptosis. Three
signaling pathways, IRE1α, PERK, and ATF6 pathways, modulate
UPR upon ER stress induction. The downstream signals of all
three pathways regulate the transcription of their target genes. We
hypothesized that miR-99b-5p/miR-100-5p might also be one of
the target genes. However, we still need more studies to verify our
hypothesis.
Taken together, increasing evidences suggest that mTOR
pathway may be a critical regulator of Aβ-associated pathologies.
Our findings about the dynamic alteration ofmiR-99b-5p/100-5p-
mTORpathway during the progression of Aβ injuries provide fur-
ther insight toward our understanding of Aβ-related AD patho-
genesis. Recently, many scientists in the field are taking effort
to look for new biomarkers for AD diagnosis, and circulating
miRNAs have been regarded as promising and feasible approach
in clinical. In our study, we also investigated the expression lev-
els of miR-99b-5p/100-5p in the plasma of APP/PS1 mice. The
differences of their levels between APP/PS1 and WT mice were
not significant at some stages. It might be due to the small sample
size included in our study. However, we still saw an interesting
trend that plasma miRNA levels were inversely correlated with
that of cortexes. Further investigations on animal models as well
as AD patients are needed to address the underlying mechanism
of how the pathological progression of AD in central nervous
system affects the copy numbers of miRNAs in peripheral plasma
in order to provide novel insights into non-invasive diagnostic
methodology for AD.
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